Biotech company Monopar Therapeutics (NASDAQ:MNPR) has updated its planned IPO offering. Monopar had planned to raise $40 million back in[…]
Read moreBiotech company Monopar Therapeutics (NASDAQ:MNPR) has updated its planned IPO offering. Monopar had planned to raise $40 million back in[…]
Read more